Latest stories on JNJ
Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock
Yahoo Finance67 · bullishgeneral
J&J cleared in talc-related cancer lawsuit in California
Seeking Alpha67 · bullishgeneral
Jim Cramer Highlights Johnson & Johnson Having No Big Patent Expirations
Yahoo Top58 · neutralanalyst
Alvotech seeks U.S. nod for biosimilars to J&J’s Simponi and Regeneron’s Eylea again
Seeking Alpha67 · bullishproduct/pr
This Dividend King Is the Safest Dow Stock to Buy and Hold for 20 Years
Yahoo Top77 · bullishproduct/pr
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Seeking Alpha42 · neutralgeneral
J&J lupus drug meets primary endpoint in Phase 2 study
Seeking Alpha67 · bullishproduct/pr
Nanobiotix Extends Cash Runway to 2029 as Early Lung Cancer Data and Accelerated Phase 3 Plan Advance JNJ-1900
TipRanks61 · neutralproduct/pr
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic
Yahoo Finance58 · neutralproduct/pr
Jim Cramer Notes “Merck’s Cancer Dominance Has Been Challenged of Late By JNJ”
Yahoo Top47 · neutralanalyst
Is Johnson & Johnson (JNJ) One of the Best Dividend Paying Stocks to Buy Right Now?
Yahoo Top61 · neutralgeneral
J&J seeks expanded use for drug after positive head and neck cancer study
Seeking Alpha67 · bullishproduct/pr
J&J study suggests earlier use of prostate cancer drug improves outcomes
Seeking Alpha61 · neutralproduct/pr
4 stocks to watch on Friday: JNJ, UNH, COST, and ADSK
Seeking Alpha58 · neutralgeneral